Industrial Alliance Investment Management Inc. Protagonist Therapeutics, Inc Transaction History

Industrial Alliance Investment Management Inc.

$196 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$7.06 - $25.52 $400,266 - $1.45 Million	-56,695 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$23.34 - $36.08 $432,723 - $668,923	-18,540 Reduced 24.64%	56,695 $1.34 Million
Q4 2021 Feb 14, 2022	BUY	$17.63 - $37.1 $1.28 Million - $2.7 Million	72,662 Added 2824.02%	75,235 $2.57 Million
Q4 2021 Feb 10, 2022	BUY	$17.63 - $37.1 $45,361 - $95,458	2,573 New	2,573 $75.2 Million

Others Institutions Holding PTGX

# of Institutions

248

Shares Held

56.7M

Call Options Held

76.3K

Put Options Held

114K

Farallon Capital Management LLC San Francisco, CA

5.86M
Shares

$230 Million
1.32% of portfolio
Black Rock Inc. New York, NY

5.76M
Shares

$226 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.43M
Shares

$213 Million
3.89% of portfolio
Vanguard Group Inc Valley Forge, PA

4.22M
Shares

$166 Million
0.0% of portfolio
State Street Corp Boston, MA

3.18M
Shares

$125 Million
0.01% of portfolio

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.93B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Industrial Alliance Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Industrial Alliance Investment Management Inc. with notifications on news.

Account